Latest filing published 04 Dec 2025 for Immucell CORP, €11k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 5 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +85.1%Entry US$5.64 · Close 22 Oct 2026 US$10.44
- +100.4%Entry US$5.21 · Close 22 Oct 2026 US$10.44
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Boekhorst Paul Francis Olivier te: trading record in brief
Boekhorst Paul Francis Olivier te discloses dealings in Immucell Corp to SEC (Form 4). In total, 5 filings cover trades dated from 2 December 2025 to 4 December 2025.
The open-market record is one-sided, with 5 purchases worth €69k and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
The median purchase comes to €15k. On 5 out of 5 purchases, another insider of the same company was buying within the same 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. Ninety days after publication, 5 purchases show a median change of +24.0%, with the price up in 100% of them. This is a record of the past, not a forecast.
The record was last updated on 4 December 2025 with an open-market purchase (€11k) in Immucell Corp. The median gap between trade and publication is zero days: most filings appear on the same day. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Boekhorst Paul Francis Olivier te
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,432 shares@ US$5.5016.6% of flowCommon Stock $0.10 par value per shareSEC:0001437749-25-036913:1Canonical exit: 4 Mar 2026 (T+90)
- 3,598 shares@ US$5.04550.1% of flowCommon Stock $0.10 par value per shareSEC:0001437749-25-036913:0Canonical exit: 3 Mar 2026 (T+90)
- 2,556 shares@ US$5.0016.0% of flowCommon Stock $0.10 par value per shareSEC:0001437749-25-036794:1Canonical exit: 3 Mar 2026 (T+90)
- 3,521 shares@ US$5.0422.2% of flowCommon Stock $0.10 par value per shareSEC:0001437749-25-036794:2Canonical exit: 3 Mar 2026 (T+90)
- 3,708 shares@ US$4.868649.9% of flowCommon Stock $0.10 par value per shareSEC:0001437749-25-036794:0Canonical exit: 2 Mar 2026 (T+90)
5 of 5 declarations